Predominance of CD4+T cells in metastatic cervical lymph nodes in papillary thyroid carcinoma

被引:1
作者
Moma, Camila Aparecida [1 ]
Barreto, Icleia Siqueira [2 ]
Assumpcao, Ligia Vera Montali [1 ]
Zantut-Wittmann, Denise Engelbrecht [1 ]
机构
[1] Univ Estadual Campinas, Fac Med Sci, Dept Internal Med, Endocrinol Div, Campinas, SP, Brazil
[2] Univ Estadual Campinas, Fac Med Sci, Dept Pathol, Campinas, SP, Brazil
关键词
CD4+T lymphocyte; lymph node metastasis; lymphocytic subpopulation; papillary thyroid carcinoma; CHRONIC LYMPHOCYTIC THYROIDITIS; REGULATORY T-CELLS; HASHIMOTOS-THYROIDITIS; CANCER; ASSOCIATION; PROGNOSIS; TRENDS;
D O I
10.1530/EC-24-0135
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Papillary thyroid carcinoma has become increasingly prevalent over the years. Avoiding unnecessary treatments and the risk of complications is essential, as well as understanding the mechanisms of tumor progression and the conditions that indicate a worse prognosis. Assessment of the tumor microenvironment can allow us understand how the immune system organizes itself to contain neoplastic progression.Methods We compared characteristics related to the lymphocytic subpopulations in the thyroid tumor microenvironment and lymph nodes in two groups, with and without lymph node metastatic involvement.Results Of the 400 cases followed up at a thyroid cancer reference service, 32 were selected, of which, 13 cases did not present lymph node metastasis (N0 group) and 19 had lymph node involvement (N1 group). Clinical data were collected, and immunohistochemical reactions were performed for markers CD4, CD8, FoxP3, CD25, and CD20 in lymph nodes and peritumoral infiltrate. We found that the N1 group had larger tumor sizes, higher risk staging, higher frequency of extrathyroidal extension, shorter disease-free times, and higher expression of CD4+ T lymphocytes in lymph nodes; however, there was no difference in the expression of other markers or in the pattern of lymphocyte distribution in the lymph node.Conclusion In cervical lymph nodes, the higher frequency of CD4+ T lymphocytes is related to the presence of metastasis. However, there were no differences in lymphocytic subpopulations in the thyroid tumor microenvironment. The absence of changes in unaffected lymph nodes could not predict any tumor behavior.
引用
收藏
页数:9
相关论文
共 34 条
[11]  
Dvorkin S, Robenshtok E, Hirsch D, Strenov Y, Shimon I, Benbassat CA., Differentiated thyroid cancer is associated with less aggressive disease and better outcome in patients with coexisting Hashimoto´s thyroiditis, Journal of Clinical Endocrinology and Metabolism, 98, pp. 2409-2414, (2013)
[12]  
Lee JH, Kim Y, Choi JW, Kim YS., The association between papillary thyroid carcinoma and histologically proven Hashimoto's thyroiditis: a meta-analysis, European Journal of Endocrinology, 168, pp. 343-349, (2013)
[13]  
Song E, Jeon MJ, Park S, Kim M, Oh HS, Song DE, Kim WG, Kim WB, Shong YK, Kim TY., Influence of coexistent Hashimoto's thyroiditis on the extent of cervical lymph node dissection and prognosis in papillary thyroid carcinoma, Clinical Endocrinology, 88, pp. 123-128, (2018)
[14]  
Pilli T, Toti P, Occhini R, Castagna MG, Cantara S, Caselli M, Cardinale S, Barbagli L, Pacini F., Chronic lymphocytic thyroiditis (CLT) has a positive prognostic value in papillary thyroid cancer (PTC) patients: the potential key role of Foxp3+ T lymphocytes, Journal of Endocrinological Investigation, 41, pp. 703-709, (2018)
[15]  
Zitvogel L, Tesniere A, Kroemer G., Cancer despite immunosurveillance: immunoselection and immunosubversion, Nature Reviews Immunology, 6, pp. 715-727, (2006)
[16]  
Menicali E, Guzzetti M, Morelli S, Moretti S, Puxeddu E., Immune landscape of thyroid cancers: new insights, Frontiers in Endocrinology (Lausanne), 11, (2020)
[17]  
Ferrari SM, Fallahi P, Galdiero MR, Ruffilli I, Elia G, Ragusa F, Paparo SR, Patrizio A, Mazzi V, Varricchi G, Et al., Immune and inflammatory cells in thyroid cancer microenvironment, International Journal of Molecular Sciences, 20, (2019)
[18]  
Zou W., Regulatory T cells, tumour immunity and immunotherapy, Nature Reviews Immunology, 6, pp. 295-307, (2006)
[19]  
Cunha LL, Morari EC, Guihen AC, Razolli D, Gerhard R, Nonogaki S, Soares FA, Vassallo J, Ward LS., Infiltration of a mixture of immune cells may be related to good prognosis in patients with differentiated thyroid carcinoma, Clinical Endocrinology, 77, pp. 918-925, (2012)
[20]  
Bychkov A, Jung CK., Aberrant expression of CD20 in thyroid cancer and its clinicopathologic significance, Human Pathology, 71, pp. 74-83, (2018)